Tesla loves to put on a show, and Thursday’s Robotaxi reveal might just be the flashiest of them all.  The electric vehicle maker is slated to unveil its much-hyped Robotaxi vehicle at Warner Bros. Discovery’s movie studio in Burbank, California. For those attending, doors will open at 5 p.m. PT, with remarks beginning at 7 […]

Reliable rumors have suggested that M4 Macs are right around the corner, and now Bloomberg's Mark Gurman is forecasting a specific launch date: November 1, following a late-October announcement that mirrors last year's Halloween-themed reveal for the first M3 Macs. This date could be subject to change, and not all the products announced in October would necessarily launch on November 1—lower-end Macs are more likely to launch early, and higher-end models would be more likely to ship a bit later in the month. The list of what to expect is the same as it has been for a while: refreshed 14- and 16-inch MacBook Pros with M4, M4 Pro, and M4 Max chips, a new M4 version of the 24-inch iMac, and an M4 update to the Mac mini that leapfrogs the M3 entirely. These will all be the first Macs to get the M4, following its unexpected introduction in the iPad Pro earlier this year. Read full article

China reportedly hacked the wiretap systems required by U.S. internet providers under a 1994 U.S. wiretapping law.

Last year, special counsel Jack Smith asked X (formerly Twitter) to hand over Donald Trump's direct messages from his presidency without telling Trump. Refusing to comply, X spent the past year arguing that the gag order was an unconstitutional prior restraint on X's speech and an "end-run" around a record law shielding privileged presidential communications. Under its so-called free speech absolutist owner Elon Musk, X took this fight all the way to the Supreme Court, only for the nation's highest court to decline to review X's appeal on Monday. It's unclear exactly why SCOTUS rejected X's appeal, but in a court filing opposing SCOTUS review, Smith told the court that X's "contentions lack merit and warrant no further review." And SCOTUS seemingly agreed. Read full article

The Central Consumer Protection Authority, India’s consumer rights regulator, has sent a show-cause notice to Ola Electric over alleged violation of consumer rights, escalating troubles for the leading electric vehicle maker whose shares dropped 9% earlier on Monday, The notice, issued on Monday, gives the Bengaluru-headquartered firm 15 days to respond to allegations that include […]

The legal saga over Martin Shkreli's infamous 5,000 percent price hike of a life-saving anti-parasitic drug has ended with a flat denial from the highest court in the land. On Monday, the Supreme Court rejected Shkreli's petition to appeal an order to return $64.6 million in profits from the pricing scheme of Daraprim, a decades-old drug used to treat toxoplasmosis. The condition is caused by a single-celled parasite that can be deadly for newborns and people with compromised immune systems, such as people who have HIV, cancer, or an organ transplant. Federal prosecutors successfully argued in courts that Shkreli orchestrated an illegal anticompetitive scheme that allowed him to dramatically raise the price of Daraprim overnight. When Shkreli and his pharmaceutical company, Vyera (formerly Turing), bought the rights to the drug in 2015, the price of a single pill jumped to $750 after being priced between $13.50 and $17.50 earlier that year. And Shkreli quickly came to epitomize callous greed in the pharmaceutical industry. Read full article